5,6,7,8-Tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-8-amine, 98%, 500mg

3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)uridine, 95%, 25g

tert-Butyl tetrahydropyrimidine-1(2H)-carboxylate, 95.0%, 100mg

Oxazole-5-carboxamide, 95.0%, 100mg

Naphthalen-1-ylmethanamine hydrochloride, 97%, 1g

2-Metoxietanol, 99% min, para síntesis, 1 L, envase de vidrio

1-(Pyrimidin-2-yl)-1H-pyrazole-5-carbaldehyde, 95.0%, 1g

2-cyclopropyl-1H-benzo[d]imidazole-5-carboxylic acid, 95.0%, 1g

8-oxo-8-(2-thienyl)octanoic acid, 97.0%, 1g

2-(2-Methylpyridin-4-yl)oxazole-4-carboxylic acid, 97%, 1g

tert-Butyl (2-(2-(2-hydroxyethoxy)ethoxy)ethyl)carbamate, 97.0%, 100g

3-Bromo-2-fluorobenzylamine, 95.0%, 100mg

Bis(pentafluorophenyl)carbonate, 97.0%, 1g